Austin Retina Associates
Eric Viet Le is an experienced healthcare professional with a background in ophthalmic assistance and patient care. Currently serving as an Ophthalmic Technician at Austin Retina Associates since July 2018, Eric has also held roles as a Unit Clerk and Patient Care Technician at St. David's Medical Center since May 2014. In addition, Eric is a Research Assistant at Lee Lab, focusing on behavioral neuroscience, specifically investigating the brain regions associated with environmental cues and alcohol addiction in rats to aid in reducing relapses in addiction patients. Eric holds a Master’s degree in Medical Sciences from UNT Health Science Center and a Bachelor of Science and Arts degree in Neuroscience from The University of Texas at Austin.
This person is not in the org chart
Austin Retina Associates
Austin Retina Associates has been serving the citizens of Austin and surrounding communities since 1978. It is the largest retinal specialty group in Central Texas. Each of the highly respected retina physicians at Austin Retina Associates is a board-certified, licensed ophthalmologist and fellowship-trained retinal surgeon who is an expert in managing diseases involving the retina, vitreous and macula. The Austin Retina specialists concentrate on diabetic eye disease, retinal detachment, macular edema, epiretinal membrane, floaters, retinal surgery and more. Between them is over 100 years of combined medical knowledge and professional experience in providing patients with the very best vitreoretinal care available. ARA continues to remain at the forefront of retinal specialty practices by utilizing cutting-edge diagnostic equipment while offering state-of-the-art surgical procedures and pharmaceutical treatment regimens. ARA collaborates with referring ophthalmologists, optometrists, primary care physicians and specialists to comprehensively treat vitreoretinal disease. Additionally, Austin Retina Associates is nationally recognized for its participation in ground-breaking, pivotal clinical trials for 25 years, which has allowed us to offer our patients the opportunity to receive novel procedures and therapies through enrollment in research studies.